Q: What is Denosumab used for?

Denosumab is used to treat: osteoporosis bone loss giant cell tumor of bone and others

Q: What are the brand names for Denosumab?

Denosumab is sold under the brand names Prolia and Xgeva .

Q: What are the active ingredients in Denosumab?

The active ingredient in Denosumab is denosumab .

Q: What are the side effects of Denosumab?

Common side effects of Denosumab may include: back pain joint pain extremity pain Always consult with a healthcare professional about potential side effects.

Q: What drug class is Denosumab?

Denosumab belongs to the RANKL inhibitor drug class.

Q: What is the dosage of Denosumab and how do I take it?

Administration Denosumab is given as an injection just under the skin (subcutaneously). A healthcare professional usually administers the injection in a medical office or clinic. Common injection sites include the upper arm, the upper thigh, or the stomach area (abdomen). Frequency The schedule for injections depends on the specific condition being treated: For bone loss or osteoporosis, the injection is generally given once every six months. For certain types of bone tumors or to prevent bone problems caused by cancer, the injection is typically given once every four weeks. Supplements While receiving this medication, your doctor may instruct you to take calcium and vitamin D supplements to help maintain healthy mineral levels in your body. Missed Doses If you miss an appointment for your injection, contact your healthcare provider right away to reschedule. The medication should be given as soon as possible, and your next dose will be scheduled based on the date of that injection.

Q: Is Denosumab safe during pregnancy and breastfeeding?

Pregnancy Denosumab may cause harm to an unborn baby and is generally not recommended for use during pregnancy. Healthcare providers typically advise individuals who can become pregnant to use effective birth control methods during treatment and for at least 5 months after the last dose. If you become pregnant while using this medication, you should contact your doctor immediately to discuss the potential risks. Breastfeeding It is not known whether denosumab passes into human breast milk. Because of the potential for serious side effects in a nursing infant, healthcare providers usually recommend either discontinuing breastfeeding or stopping the medication. The decision depends on the medical necessity of the drug for the mother. Consult with a healthcare professional to weigh the benefits and risks before breastfeeding while using this medication.

Q: What forms and strengths does Denosumab come in?

Available Forms Denosumab is available as a clear, colorless to pale yellow liquid solution. It is designed for subcutaneous injection, which means it is injected into the fatty tissue just beneath the skin. It is typically supplied in the following formats: Single-dose prefilled syringes: These are used for specific treatment schedules, often administered once every six months. Single-dose vials: These are used for dosing schedules that may occur more frequently, such as every four weeks. Strengths The medication comes in different concentrations depending on the condition being treated. Common strengths include: 60 milligrams (mg) per 1 milliliter (mL) of solution. 120 milligrams (mg) per 1.7 milliliters (mL) of solution. Because the dosage and frequency depend on the specific medical reason for the treatment, denosumab is usually administered by a healthcare provider in a clinical setting.

Question 1

What is Denosumab?

Accepted Answer

Denosumab is a type of medication known as a monoclonal antibody that works as a bone-modifying agent. It functions by targeting and blocking a specific protein in the body that is responsible for the breakdown of bone tissue.

By inhibiting this process, the medication helps to increase bone mass and maintain bone strength. This action supports the structural integrity of the skeletal system.

Question 2

What is Denosumab used for?

Accepted Answer

Denosumab is used to treat:

osteoporosis
bone loss
giant cell tumor of bone
and others

Question 3

How does Denosumab work?

Accepted Answer

Bone is a living tissue that is constantly being broken down and replaced. In a healthy body, there is a balance between the cells that build bone and the cells that dissolve it. Denosumab works by targeting the specific process that leads to bone loss.

The medication is a monoclonal antibody designed to recognize and bind to a protein called RANK ligand. This protein is essential for the formation, function, and survival of osteoclasts, which are the cells that break down bone. By binding to this protein, denosumab prevents it from activating the osteoclasts.

When the activity of these bone-dissolving cells is reduced, the following effects occur:

Bone breakdown is slowed down.
Bone mass and density are increased.
Bones become stronger and less likely to break or fracture.

In cases where cancer has spread to the bones, this process also helps to limit bone destruction and reduce the risk of complications like fractures or bone pain.

Question 4

What are the brand names for Denosumab?

Accepted Answer

Denosumab is sold under the brand names Prolia and Xgeva.

Question 5

What are the active ingredients in Denosumab?

Accepted Answer

The active ingredient in Denosumab is denosumab.

Question 6

What are the side effects of Denosumab?

Accepted Answer

Common side effects of Denosumab may include:

back pain
joint pain
extremity pain

Always consult with a healthcare professional about potential side effects.

Question 7

What drug class is Denosumab?

Accepted Answer

Denosumab belongs to the RANKL inhibitor drug class.

Question 8

What is the dosage of Denosumab and how do I take it?

Accepted Answer

Administration

Denosumab is given as an injection just under the skin (subcutaneously). A healthcare professional usually administers the injection in a medical office or clinic. Common injection sites include the upper arm, the upper thigh, or the stomach area (abdomen).

Frequency

The schedule for injections depends on the specific condition being treated:

For bone loss or osteoporosis, the injection is generally given once every six months.
For certain types of bone tumors or to prevent bone problems caused by cancer, the injection is typically given once every four weeks.

Supplements

While receiving this medication, your doctor may instruct you to take calcium and vitamin D supplements to help maintain healthy mineral levels in your body.

Missed Doses

If you miss an appointment for your injection, contact your healthcare provider right away to reschedule. The medication should be given as soon as possible, and your next dose will be scheduled based on the date of that injection.

Question 9

Is Denosumab safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Denosumab may cause harm to an unborn baby and is generally not recommended for use during pregnancy. Healthcare providers typically advise individuals who can become pregnant to use effective birth control methods during treatment and for at least 5 months after the last dose. If you become pregnant while using this medication, you should contact your doctor immediately to discuss the potential risks.

Breastfeeding

It is not known whether denosumab passes into human breast milk. Because of the potential for serious side effects in a nursing infant, healthcare providers usually recommend either discontinuing breastfeeding or stopping the medication. The decision depends on the medical necessity of the drug for the mother. Consult with a healthcare professional to weigh the benefits and risks before breastfeeding while using this medication.

Question 10

What forms and strengths does Denosumab come in?

Accepted Answer

Available Forms

Denosumab is available as a clear, colorless to pale yellow liquid solution. It is designed for subcutaneous injection, which means it is injected into the fatty tissue just beneath the skin. It is typically supplied in the following formats:

Single-dose prefilled syringes: These are used for specific treatment schedules, often administered once every six months.
Single-dose vials: These are used for dosing schedules that may occur more frequently, such as every four weeks.

Strengths

The medication comes in different concentrations depending on the condition being treated. Common strengths include:

60 milligrams (mg) per 1 milliliter (mL) of solution.
120 milligrams (mg) per 1.7 milliliters (mL) of solution.

Because the dosage and frequency depend on the specific medical reason for the treatment, denosumab is usually administered by a healthcare provider in a clinical setting.

Question 11

What is the FDA approval status of Denosumab?

Accepted Answer

The U.S. Food and Drug Administration (FDA) has approved denosumab for several specific uses, including:

Treatment of osteoporosis in postmenopausal women and in men at high risk for bone fracture.
Treatment of bone loss in patients receiving certain treatments for prostate or breast cancer.
Treatment of giant cell tumor of bone that cannot be removed by surgery or where surgery is likely to cause severe morbidity.
Treatment of high calcium levels caused by cancer (hypercalcemia of malignancy) when other treatments have not worked.

In early 2024, the FDA added a Boxed Warning—its most serious safety notification—to the prescribing information for certain denosumab products. This warning highlights an increased risk of severe hypocalcemia (dangerously low blood calcium levels) in patients with advanced chronic kidney disease, particularly those on dialysis or those with a condition called mineral and bone disorder.

Severe hypocalcemia can lead to serious complications, including hospitalization, seizures, or death. The FDA requires healthcare providers to screen patients for kidney disease before starting the medication and to monitor calcium levels closely in those at high risk.

The FDA has approved biosimilar versions of denosumab. These medications are highly similar to and have no clinically meaningful differences from the original biological product in terms of safety, purity, and potency.

Question 12

What should I know about Denosumab and cost?

Accepted Answer

Factors Influencing Cost

The total price of denosumab treatment is determined by several variables, including the specific brand prescribed and the patient's insurance plan. Because this medication is an injection administered by a healthcare professional, costs typically include both the drug and the clinical service fee for the office visit.

Insurance and Assistance

Coverage for denosumab is common under most major insurance plans, including Medicare, as it is usually administered in a doctor's office or outpatient clinic. For patients facing high out-of-pocket costs, support may be available through:

Co-pay Assistance: Programs for eligible patients with commercial insurance to help reduce out-of-pocket expenses.
Patient Assistance Programs: Programs offered by manufacturers for those without insurance or who meet specific financial criteria.

Biosimilar Options

The FDA has approved biosimilar versions of denosumab. These products are highly similar to the original reference drugs and may offer a more affordable treatment option depending on insurance formulary preferences and pharmacy benefit designs.

Denosumab

📋Overview

How It Works

Uses

Brand Names

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Denosumab

Hospitals.net Disclosure